HackerFeeds
All ransomware incidents
nnjei.com

Ransomware group thegentlemen hits Northern NJ Eye Institute

MEDIUM
·Healthcare·US·2026-09-29

Northern NJ Eye Institute — a healthcare target operating in US has been listed by the thegentlemen ransomware group on 2026-09-29. The information below reflects what the threat actor has publicly claimed on their leak site; the details have not been independently verified.

Incident Report

Target OrganizationNorthern NJ Eye Institute
Threat Group
thegentlemen
Summarynnjei.com zoominfo.com/c/northern-nj-eye-institute/70059294 Northern New Jersey Eye Institute / NNJEI (30+ years, nnjei.com, South Orange, NJ) is a family-run ophthalmology practice and ambulatory surgery center with clinics in South Orange, West Caldwell and Elizabeth. It treats cataracts (its signature "no-needle, no-stitch, no-patch" surgery), LASIK/LASEK/PRK vision correction, glaucoma, corneal and retinal disease, diabetic eye care and cosmetic eye services, with its own AAAHC-accredited operating room and acceptance of Medicare plus 13+ insurance plans. Its standout edge is clinical research: lead surgeon Charles J. Crane, MD (4.9/5 from 127 Zocdoc reviews, NJ Top Docs 2024) was among the first ~100 doctors in the US to implant the Glaukos iDose TR and among fewer than 15 in FDA trials for iStent infinite — pioneering MIGS glaucoma treatments, with results published in 2025–26 journals. The practice books about $3.2M revenue with 15–18 staff and holds a solid 79/100 CMS MIPS
Date of Breach2026-09-29
Discovery Date2026-09-30
RegionUS
Target Domainnnjei.com
Business SectorHealthcare
Severity
MEDIUM

Claim by thegentlemen

nnjei.com zoominfo.com/c/northern-nj-eye-institute/70059294 Northern New Jersey Eye Institute / NNJEI (30+ years, nnjei.com, South Orange, NJ) is a family-run ophthalmology practice and ambulatory surgery center with clinics in South Orange, West Caldwell and Elizabeth. It treats cataracts (its signature "no-needle, no-stitch, no-patch" surgery), LASIK/LASEK/PRK vision correction, glaucoma, corneal and retinal disease, diabetic eye care and cosmetic eye services, with its own AAAHC-accredited operating room and acceptance of Medicare plus 13+ insurance plans. Its standout edge is clinical research: lead surgeon Charles J. Crane, MD (4.9/5 from 127 Zocdoc reviews, NJ Top Docs 2024) was among the first ~100 doctors in the US to implant the Glaukos iDose TR and among fewer than 15 in FDA trials for iStent infinite — pioneering MIGS glaucoma treatments, with results published in 2025–26 journals. The practice books about $3.2M revenue with 15–18 staff and holds a solid 79/100 CMS MIPS

Posted by the thegentlemen threat actor on its public leak site. This is the group's own statement and has not been independently verified by HackerFeeds.

Disclaimer

HackerFeeds does not engage in the exfiltration, downloading, taking, hosting, viewing, reposting, or disclosure of any stolen information. All breach data reported here is sourced from publicly available threat intelligence feeds for awareness purposes only.